Results from different databases, such as the Tumor Immunity Estimation Resource and The Cancer Genome Atlas databases, have shown reduced INMT expression in several cancers, including cancer of the bladder, breast, cervix, colon, head and neck, esophagus, kidney, lung, prostate, skin, thyroid, and uterus [17,90]. This evidence concerns the gene INMT and neoplasm.